Effect of inhaled hyaluronic acid (HA) on exercised induced bronchoconstriction (EIB).
Telenga
E D
ED
Kerstjens
H A M
HA
D000276:Adjuvants, Immunologic / Q000008:administration & dosage / Q000493:pharmacokinetics / Q000627:therapeutic use*; D000280:Administration, Inhalation; D000328:Adult; D001250:Asthma, Exercise-Induced / Q000503:physiopathology / Q000517:prevention & control*; D001985:Bronchial Provocation Tests; D016084:Bronchoconstriction; D018592:Cross-Over Studies; D005541:Forced Expiratory Volume / Q000187:drug effects; D006801:Humans; D006820:Hyaluronic Acid / Q000008:administration & dosage / Q000493:pharmacokinetics / Q000627:therapeutic use*; D016210:Methacholine Chloride
D000276:Adjuvants, Immunologic; D016210:Methacholine Chloride; D006820:Hyaluronic Acid